Flagship VentureLabs IV, LLC's Net Worth
$4.73 Billion
Who is Flagship VentureLabs IV, LLC?
Flagship VentureLabs IV, LLC has an estimated net worth of $4.73 Billion. This is based on reported shares across multiple companies, which include Moderna, Inc., Kaleido Biosciences, Inc., Seres Therapeutics, Inc., Rubius Therapeutics, Inc., Syros Pharmaceuticals, Inc., Axcella Health Inc., and Evelo Biosciences, Inc..
SEC CIK
Flagship VentureLabs IV, LLC's CIK is 0001642578
Past Insider Trading and Trends
2018 was Flagship VentureLabs IV, LLC's most active year for acquiring shares with 20 total transactions. Flagship VentureLabs IV, LLC's most active month to acquire stocks was the month of June. 2018 was Flagship VentureLabs IV, LLC's most active year for disposing of shares, totalling 24 transactions. Flagship VentureLabs IV, LLC's most active month to dispose stocks was the month of April. 2019 saw Flagship VentureLabs IV, LLC paying a total of $10,000,000.00 for 7,154,671 shares, this is the most they've acquired in one year. In 2016 Flagship VentureLabs IV, LLC cashed out on 17,758,490 shares for a total of $27,600,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Moderna, Inc. (MRNA) Snapshot price: $99.38
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 47.34M |
—
|
—
| 47.34M |
Dec 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kaleido Biosciences, Inc. (KLDO) Snapshot price: $0.000001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +158.12% | 1.12M |
—
|
—
| 1.83M |
Mar 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Seres Therapeutics, Inc. (MCRB) Snapshot price: $1.025
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -12.02% | -2.00M |
$27.60 | -$27,600,000.00 | 14.64M |
May 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Rubius Therapeutics, Inc. (RUBY) Snapshot price: $0.053
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +185.29% | 33.3M |
—
|
—
| 51.27M |
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Syros Pharmaceuticals, Inc. (SYRS) Snapshot price: $7.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -35.64% | -1.66M |
—
|
—
| 2.99M |
Aug 17
| |||
Form 4
| +47.55% | 4.59M |
$12.50 | $5,000,000.00 | 14.25M |
Jul 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||